Loading...
Décision de pays ou tout autre communication (DEC)
  |  
BCH-DEC-DE-111658-3   |   PDF   |   Imprimer   |  
| 
published: 22 févr. 2017 last updated: 23 nov. 2020
Amendement
Non
Informations générales
6786-01-0085 (adv. 42010-0085); Decision regarding the risk assessment of a deliberate release (field trial) of genetically modified maize (Zea mays), offspring of T25, issued by the German Competent Authority
EN
14 mai 1998
Oui
Sujet de la décision, notification, communication ou déclaration :
  • Décisions sur les OVM destinés à une introduction intentionnelle dans l'environnement (conformément à l'article 10 ou au cadre réglementaire national)
OVM destinés à une introduction intentionnelle dans l'environnement
Non
Non
Oui
Non
Non
Résultat de la décision
Approbation de l'importation/utilisation de l'OVM avec conditions
-  Fertile plant material has to be transported and stored in closed and clearly labelled repositories at any time outside the release site and laboratory. The spillage of seeds has to be avoided.
If flowers are transported outside of the field site the spreading of pollen has to be prevented.
-  All machines that have been used on the release site have to be thoroughly cleaned on the release site.
-  The germination capacity of all plant material that is not moved to a genetic engineering facility All remaining fertile plant material, including the non-genetically modified maize shelter cropsplanted to surround the field site and harvested corncobs of those has to be destroyed by chopping and subsequent digging under the soildisruption of their germination capacity.
-  IInspection of the release site has to be conducted in the year following the observation of genetically modified maize volunteers. The follow-up inspection needs to include the whole release site and a 5 m band around the site. During the vegetation period the release site must be inspected for transgenic volunteer maize at least once every four weeks. The inspection period has to be extended for another year if maize volunteers were observed, and the volunteer plants have to be destroyed.
EN
To comply with requirements of Directive 90/220/EEC, Gentechnikgesetz (German Gene Technology Act): reduce possibility of GMO spread/establishment.
EN
Évaluation des OVM et des risques
  • BCH-LMO-SCBD-14767-14 Organisme vivant modifié ACS-ZMØØ3-2 - Liberty Link™ maize
    Bayer CropScience | Résistance aux antibiotiques (Ampicilline), Résistance aux herbicides (Glufosinate)
  • BCH-RA-DE-111657-3 Évaluation des risques générée par un processus de réglementation 6786-01-0085 (adv. 42010-0085) Summary of the risk assessment of a deliberate release (field trial) of genetically modified maize (Zea mays), offspring of T25, issued by the German Competent Authority
    ACS-ZMØØ3-2 - Liberty Link™ maize | Maize, Corn, MAIZE, Résistance aux herbicides, Résistance aux antibiotiques
Document sur la décision, la communication, la notification ou la déclaration
Informations supplémentaires
-  type of decision: field trial
-  LMO: offspring of T25
-  legal basis: Directive 90/220/EEC, Gentechnikgesetz (German Gene Technology Act)
-  scope: test of field performance of LMO
-  authorization valid from 14 May 1998 to 31 December 2003
-  locations: 1 experimental fieldslocated in 1 village in Germany, for details refer to the German LMO/GMO lcation register (https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
-  size: 2700 m²/site/year
-  max. 27.000 LMO/site/year

-  There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/97/85

The decision on this deliberate release was made by the Robert Koch Institute (RKI).
The RKI was the competent national authority for the German Gene Technology Act before the competences were transferred to the Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, BVL) on April 1st 2004. Deliberate releases that were authorized by the RKI prior to this date are now handled by the BVL.
EN